Interactions between killer cell immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) class I ligands regulate the development and response of human natural killer (NK) cells. Natural selection drove an allele-level group A KIR haplotype and the HLA-C1 ligand to unusually high frequency in the Japanese, who provide a particularly informative population for investigating the mechanisms by which KIR and HLA polymorphism influence NK cell repertoire and function. HLA class I ligands increase the frequencies of NK cells expressing cognate KIR, an effect modified by gene dose, KIR polymorphism, and the presence of other cognate ligand–receptor pairs. The five common Japanese KIR3DLI allotypes have distinguishable inhibitory capacity, frequency of cellular expression, and level of cell surface expression as measured by antibody binding. Although KIR haplotypes encoding 3DL1*001 or 3DL1*005, the strongest inhibitors, have no activating KIR, the dominant haplotype encodes a moderate inhibitor, 3DL1*01502, plus functional forms of the activating receptors 2DL4 and 2DS4. In the population, certain combinations of KIR and HLA class I ligand are overrepresented or underrepresented in women, but not men, and thus influence female fitness and survival. These findings show how KIR–HLA interactions shape the genetic and phenotypic KIR repertoires for both individual humans and the population.
Skip Nav Destination
Article navigation
20 March 2006
Article|
March 13 2006
Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
Makoto Yawata,
Makoto Yawata
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
Search for other works by this author on:
Nobuyo Yawata,
Nobuyo Yawata
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
Search for other works by this author on:
Monia Draghi,
Monia Draghi
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
Search for other works by this author on:
Ann-Margaret Little,
Ann-Margaret Little
2Histocompatibility Laboratories, The Anthony Nolan Trust
3Department of Haematology, The Royal Free Hospital, London, NW3 2QG, England, UK
Search for other works by this author on:
Fotini Partheniou,
Fotini Partheniou
2Histocompatibility Laboratories, The Anthony Nolan Trust
Search for other works by this author on:
Peter Parham
Peter Parham
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
Search for other works by this author on:
Makoto Yawata
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
Nobuyo Yawata
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
Monia Draghi
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
Ann-Margaret Little
2Histocompatibility Laboratories, The Anthony Nolan Trust
3Department of Haematology, The Royal Free Hospital, London, NW3 2QG, England, UK
Fotini Partheniou
2Histocompatibility Laboratories, The Anthony Nolan Trust
Peter Parham
1Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
CORRESPONDENCE Peter Parham: [email protected] OR Makoto Yawata: [email protected]
Abbreviations used: KIR, killer cell immunoglobulin-like receptor; LD, linkage disequilibrium; mfi, mean fluorescence intensity.
M. Yawata and N. Yawata contributed equally to this work.
Received:
September 19 2005
Accepted:
February 01 2006
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2006
J Exp Med (2006) 203 (3): 633–645.
Article history
Received:
September 19 2005
Accepted:
February 01 2006
Connected Content
This article has been corrected
Correction
Citation
Makoto Yawata, Nobuyo Yawata, Monia Draghi, Ann-Margaret Little, Fotini Partheniou, Peter Parham; Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function . J Exp Med 20 March 2006; 203 (3): 633–645. doi: https://doi.org/10.1084/jem.20051884
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Connected Content
Advertisement